Detail page

Knowledge Web

Person

Hendrik Luxenburger

Arzt

Name	Hendrik Luxenburger
Place	Saarbrücken (Geburtsort) Deutschland
Gender	männlich
Academic degree	Dr. med.
Profession	Arzt (characteristic profession)
Further information	Dissertation 2020, Albert-Ludwigs-Universität Freiburg im Breisgau, Medizinische Fakultät
Source	FreiDok plus
Record type	Person
GND-Identifier	1175674362
Record ID	1175674362
Involved in show all Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial Impaired SARS-CoV-2-specific CD8+ T cells after infection or vaccination but robust hybrid t cell immunity in patients with multiple myeloma MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC Decreased level of serum NT-proCNP associates with disease severity in COVID-19 Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients Decreased level of serum NT-proCNP associates with disease severity in COVID-19 Liver-resident CD8+ T cells in viral hepatitis: not always good guys Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals Survival prediction using the Freiburg index of post-TIPS survival (FIPS) in critically ill patients with acute- on chronic liver failure: A retrospective observational study Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells Virushepatitis – wann daran denken? Charakterisierung Virus-spezifischer CD8+ T-Zellantworten bei chronischen Hepatitis C Genotyp 1 und 4 - Infektionen Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load HCV-specific T cell responses during and after chronic HCV infection

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Hendrik Luxenburger

Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial

Impaired SARS-CoV-2-specific CD8+ T cells after infection or vaccination but robust hybrid t cell immunity in patients with multiple myeloma

MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC

Decreased level of serum NT-proCNP associates with disease severity in COVID-19

Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients

Decreased level of serum NT-proCNP associates with disease severity in COVID-19

Liver-resident CD8+ T cells in viral hepatitis: not always good guys

Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis

SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease

SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants

COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation

COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation

SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals

Survival prediction using the Freiburg index of post-TIPS survival (FIPS) in critically ill patients with acute- on chronic liver failure: A retrospective observational study

Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine

Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants

Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells

Virushepatitis – wann daran denken?

Charakterisierung Virus-spezifischer CD8+ T-Zellantworten bei chronischen Hepatitis C Genotyp 1 und 4 - Infektionen

Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load

HCV-specific T cell responses during and after chronic HCV infection